David Rolfe - Wedgewood Partners

Holding/activity history for  Edwards Lifesciences Corp. (EW)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2024   Q3 359,257 4.34 Add 1.36% 0.06 $66.52
2024   Q2 354,427 4.74 Add 44.40% 1.46 $65.54
2024   Q1 245,451 4.43 Reduce 2.07% 0.09 $90.16
2023   Q4 250,652 4.55 Add 29.34% 1.03 $86.26
2023   Q3 193,797 3.21 Reduce 38.51% 2.01 $69.28
2023   Q2 315,173 4.79 Reduce 4.51% 0.23 $94.33
2023   Q1 330,070 4.63 Reduce 1.11% 0.05 $82.73
2022   Q4 333,760 4.57 Add 0.64% 0.03 $74.61
2022   Q3 331,627 5.16 Reduce 2.66% 0.14 $82.63
2022   Q2 340,689 5.60 Reduce 4.89% 0.29 $95.09
2022   Q1 358,220 5.95 Add 1.44% 0.08 $117.72
2021   Q4 353,149 6.07 Reduce 25.28% 2.05 $129.55
2021   Q3 472,627 7.55 Reduce 2.26% 0.17 $113.21
2021   Q2 483,536 7.26 Reduce 5.91% 0.46 $103.57
2021   Q1 513,888 6.62 Reduce 13.63% 1.04 $83.64
2020   Q4 594,956 8.07 Reduce 5.82% 0.50 $91.23
2020   Q3 631,718 7.97 Reduce 5.51% 0.46 $79.82
2020   Q2 668,542 7.83 Add 181.85% 5.05 $69.11
2020   Q1 237,200 8.48 Reduce 36.59% 4.89 $188.62
2019   Q4 374,062 8.85 Reduce 21.87% 2.48 $233.29
2019   Q3 478,789 9.33 Reduce 7.98% 0.81 $219.91
2019   Q2 520,293 8.14 Reduce 21.27% 2.20 $184.74
2019   Q1 660,819 9.23 Reduce 19.52% 2.24 $191.33
2018   Q4 821,132 8.35 Add 0.27% 0.02 $153.17
2018   Q3 818,960 7.15 Reduce 8.13% 0.63 $174.10
2018   Q2 891,410 6.55 Reduce 21.28% 1.77 $145.57
2018   Q1 1,132,341 7.27 Reduce 15.48% 1.33 $139.52
2017   Q4 1,339,762 6.11 Reduce 0.24% 0.01 $112.71
2017   Q3 1,343,047 5.01 Add 55.92% 1.80 $109.31
2017   Q2 861,348 3.12 Reduce 24.25% 1.00 $118.24
2017   Q1 1,137,072 2.75 Buy 2.75 $94.07